FDA alerts consumers about the CBD products
Washington Post - 28-Nov-2019CBD products developing companies are frustrated with the FDA's lack of of clear regulations
Join the club for FREE to access the whole archive and other member benefits.
Dr. A. Abernethy is a Principal Deputy Commissioner and Acting CIO at US FDA
Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is an internationally recognized clinical data expert and clinical researcher. Her areas of expertise include cancer data, real world evidence, clinical trials, health services research, patient reported outcomes (PROs), clinical informatics, and patient-centered care.
Visit website: https://www.fda.gov/about-fda/fda-organization/amy-abernethy
See also: Food and Drug Administration (FDA) - Ensuring safety of drugs, medical supplies and food which is used daily.
Details last updated 01-Dec-2019
CBD products developing companies are frustrated with the FDA's lack of of clear regulations